Assorted News from the Last Week:
Spending package extends medicare telehealth flexibilities for three months and Gabriella Miller Kids First 2.0 reauthorization passes in standalone bill. Other childhood cancer priorities left behind. FDA approves Remestemcel-L for pediatric steroid-refractory acute graft-vs-host disease. Neurocognitive battery feasible in 3-year-olds during leukemia treatment. Saro H. Armenian, DO, MPH, discussed the unique challenges facing children diagnosed with cancer and their families and what lies on the horizon.Upcoming Webinars, Online Opportunities, and Meetings:
ACCELERATE Multi-stakeholder Conference “A Decade of Impact – and Beyond” on February 6th & 7th in Brussels Belgium. In-person and virtual registration available. Click here for more information and to register.
The 2nd Childhood Cancer Prevention Symposium will be held in Houston, TX, at Texas Children’s Hospital, February 10-13, 2025. Click here for more information and to register.